The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) Strategic alternatives process underway to maximize value creation across ...

A hypoallergenic therapeutic vaccine candidate for peanut allergy was safe and tolerable, according to a poster presented at ...

One by one, at a Clearwater town hall on Saturday, Pinellas County constituents took turns addressing a "missing" poster of Rep. Ana Paulina Luna, R-Fla., expressing discontent with President ...

According to The London Economics, the last few weeks have seen the streets of London filled with posters that have been calling out Elon Musk. The billboards, which have been placed on Tube stations, ...

today announced an upcoming poster for bezuclastinib at the 2025 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI) being held in San Diego, CA, February 28-March 3 ...

These findings were presented on March 1 on an AAAAI poster and published the day before in JAMA Network Open. “We expected Black children to be at increased risk for asthma, but I thought that ...

Their analysis, as described on a featured AAAAI poster, found short-term disruptions in the nasal microbiome that lasted more than 2 weeks but not 6 months. These and Kristal’s findings ...